The main area of OncoReview’s scientific mission is the emerging field of interdisciplinary oncology, with particular emphasis on cardio-oncology. Scientific papers published in the journal concern modern diagnostic and therapeutic methods used in this population of patients, as well as all adverse events related to anticancer treatment. Objective assessment of the benefits and risks of new oncological drugs is a unique benefit of the published works.
e-ISSN: 2450-6125 DOI: 10.24292/01.OR
Indexed in: SCOPUS: SJR 2019 = 0.125; SNIP 2019= 0.099
Polish Journals Master List: 20 points
Index Copernicus: 116.25
Polish Medical Bibliography
Vol 12 No 1(45) (2022)
in a narrative review that opens this year's first issue of “OncoReview”, a group of young Iranian scientists elegantly presents honey's potential role in the complementary treatment of breast cancer. The anti-cancer effect of honey may result from its anti-inflammatory, antimutagenic and antioxidant properties. However, it should be noted that more research is needed to improve our understanding of its positive effects and cancer.
A case report published in the “OncoWatch” section by Łesiów et al. from Warmian-Masurian Cancer Center in Olsztyn describe a place that in difficult diagnostic cases (here, in the case of suspected kidney cancer in a patient with significant body deformation), may have advanced laparoscopic surgery.
I wish you an interesting reading,
Radosław Grabysa, MD, PhD, Associate Professor